Pharmaceutical Products
NME (New Molecule Entity) products
- JPI-289 (Stroke)- JPI-547 (Solid Tumors) - JP-1366 (GastroEsophageal Reflux Disease) - JP-2266 (Type I Diabetes Mellitus) IMD (Incrementally Modified Drug) products
- JLP-1920: Lumbar spinal stenosis- JLP-2004: Pain - JLP-2103: Asthma / Rhinitis - JLP-1901: Hepatitis B - JLP-2008: Diabetes - ATB-101: Hypertension + Diabetes Pipeline |
Technologies
 Synthesis of Active Pharmaceutical Ingredients (APIs)Formulation Technology |
| First Name * | |
| Last Name * | |
| Title * | |
| Company * | |
| Address 1 | |
| Address 2 | |
| City | |
| Country | |
| Postal Code | |
| E-mail Address * | |
| Phone * | |
| Fax | |
| Summary Description of Potential Opportunity * (2,000 character's limit) |
|
| Type of Business * | |
| * Required Field Submit Cancel |
|
